iiinova — where your digital self keeps evolving

Springer Medicine @springermedicine.com · 01/10/2026

With #EASD2026 soon coming to a close, we bring you the key updates and latest advances in #diabetes research, treatment, and care from this year's meeting. 👉️ buff.ly/7GIjfiy #MedSky

000

Springer Medicine @springermedicine.com · 28/09/2026

Heading to Milan for #EASD2026? Why not stop by Booth L.04 to find out more about us? Not attending in person? Find our more about Springer Medicine here 👉️ buff.ly/qBZR48O #MedSky

010

Springer Medicine @springermedicine.com · 24/09/2026

New guidelines, practice-changing trial results, and showcases on how AI is changing CV care - #ESCCongress 2026 offered no shortage of developments for cardiologists to digest. Our congress hub has the key highlights and expert insights from the meeting. 👉️ buff.ly/5AFTg0f #CardioSky

010

Springer Medicine @springermedicine.com · 23/09/2026

From #ESCCongress 2026 - Dr. Kevin Damman shares the main messages from the new ESC guidelines on the management of cardiovascular disease and chronic kidney disease. Watch the full interview 👉️ buff.ly/1wiJCiC #CVD #CKD

000

Springer Medicine @springermedicine.com · 18/09/2026

From #ESCCongress 2026: Prof. Maria Bäck highlights some of the key recommendations from the first-ever ESC guidelines on cardiac rehabiliation, such as the importance of a multipronged approach and shared decision-making. 👉️ buff.ly/ihZh7Dg #CardioSky

000

Springer Medicine @springermedicine.com · 03/09/2026

❗️LAST CHANCE TO REGISTER❗️ Join our expert-led webinar to learn how to best approach difficult-to-treat rheumatoid arthritis. Register for free here 👉️ buff.ly/wO7Khfr #RheumSky #MedEd #MedSky

000

Springer Medicine @springermedicine.com · 01/09/2026

Catch up on the latest breakthroughs, innovations and clinical updates from #ESCCongress 2026 with our ESC hub. Access for free 👉️ buff.ly/LuFwFjO #CardioSky #MedSky

011

Springer Medicine @springermedicine.com · 28/08/2026

Join Prof. Elena Nikiphorou in this CME-accredited webinar to explore the key issues in difficult-to-treat RA, from its definition and underlying contributors to treatment and management strategies. Reserve your place 👉️ buff.ly/wO7Khfr #MedSky #MedEd #Arthritis

010

Springer Medicine @springermedicine.com · 26/08/2026

Don't miss a beat from #ESCCongress 2026 🩺 We will be bringing you the key highlights, guideline updates, and expert opinions from this year's meeting. In the meantime, catch up on what you missed from last year's meeting 👉️ buff.ly/LuFwFjO #CardioSky #MedNews

000

Springer Medicine @springermedicine.com · 23/08/2026

Rheumatoid arthritis symptoms can persist despite pharmacological interventions. In this CME-accredited webinar, Prof. Elena Nikiphorou discusses evidence-based strategies to manage difficult-to-treat RA. Register now 👉️ buff.ly/wO7Khfr #MedSky #MedEd

010

Springer Medicine @springermedicine.com · 07/08/2026

How can you best manage difficult-to-treat #RheumatoidArthritis? Join our expert-led webinar to explore treatment and management strategies, including the need for a personalized, multidisciplinary approach. Register now 👉️ buff.ly/ioH94Pz #RheumSky

000

Springer Medicine @springermedicine.com · 31/07/2026

Join Prof. Elena Nikiphorou to explore the key issues in difficult-to-treat #RheumatoidArthritis, from its definition and underlying contributors to treatment and management strategies. Register now for this free webinar 👉️ buff.ly/ioH94Pz #MedSky #RheumSky

042

Springer Medicine @springermedicine.com · 25/07/2026

From #EULAR2026 - Prof. Laura Coates discusses the concomitant use of #tirzepatide with ixekizumab for achieving disease control in patients with #PsoriaticArthritis and obesity. Watch the full interview 👉️ buff.ly/ckfw6EN #RheumSky

020

Springer Medicine @springermedicine.com · 24/07/2026

From #EULAR2026 - Dr. Norman Gaylis shares safety and efficacy findings for AB-101 in combination with #rituximab in patients with treatment-resistant rheumatologic diseases. Watch the full interview 👉️ buff.ly/3WFEuzh #RheumSky

000

Springer Medicine @springermedicine.com · 23/07/2026

From #EAN2026 - Prof. Jürgen Beck discusses the recent advancements in spontaneous intracranial hypotension that have made this underrecognized cause of disabling #headache a diagnosable and treatable condition. Watch now 👉️ buff.ly/FPhU4Yj #NeuroSky

000

Springer Medicine @springermedicine.com · 22/07/2026

From #EAN2026 - Dr. Miguel Miranda gives his takeaways on the 12-month ROSSINI findings for foslevodopa/foscarbidopa in #PD, the latest results for bocunebart in adults with #migraine, and the potential of GDF-15 for predicting cognitive decline. Watch now 👉️ buff.ly/PtqO7MS #NeuroSky

000

Springer Medicine @springermedicine.com · 08/07/2026

❗️ LAST CHANCE TO REGISTER❗️ #BladderCancer management is evolving rapidly and new data are redefining established treatment pathways. Join our experts as they help you to understand and implement the changes in your practice. 👉️ buff.ly/ph5uzJb -- #OncSky #UroSky

000

Springer Medicine @springermedicine.com · 01/07/2026

Catch up on the latest highlights from #EAN2026 with our congress hub, including breaking news and exclusive interviews. Access the hub for free 👉️ buff.ly/jZIsaP3 #NeuroSky #MedSky

000

Springer Medicine @springermedicine.com · 26/06/2026

Attending #EAN2026? Stop by our booth at E60 and learn more about our free #MedEd platform. Won't be there in person? Learn more about Springer Medicine here 👉️ buff.ly/HDu38SG #NeuroSky

000

Springer Medicine @springermedicine.com · 21/06/2026

From #ASCO2026 - Dr. Tian Zhang recaps the key #KidneyCancer trials from the congress, such as RAMPART and RADICAL as well as the first biomarker analysis from KEYNOTE-564. Watch the full video 👉️ buff.ly/LLItjzm #OncSky

000

Springer Medicine @springermedicine.com · 20/06/2026

From #ASCO2026 - Dr. Tian Zhang offers her highlights from the #BladderCancer sessions, covering additional analyses from pivotal trials and promising early-phase studies in the perioperative setting. Watch the full video 👉️ buff.ly/tkQqQjz #OncSky

010

Springer Medicine @springermedicine.com · 17/06/2026

From #ASCO2026 - Dr. Stephanie Lheureux presents the highlights in #OvarianCancer for the past year, focusing on the three pillars driving the changes in treatment, namely biology, patient selection, and treatment sequencing. 👉️ buff.ly/PSuYrhk #OncSky

010

Springer Medicine @springermedicine.com · 17/06/2026

#BladderCancer management is evolving rapidly and new data are redefining established treatment pathways. Join our experts as they help you to understand and implement the changes in your practice. 👉️ buff.ly/6uOWY8L -- #OncSky #UroSky

000

Springer Medicine @springermedicine.com · 16/06/2026

From #ASCO2026 - Dr. William Gradishar discusses recent developments in #BreastCancer, in particular shining a light on the role that antibody–drug conjugates have played in transforming the treatment of all subtypes. 👉️ buff.ly/VThhz2b #OncSky

010

Springer Medicine @springermedicine.com · 11/06/2026

From #ASCO2026 - Dr. Tanya Dorff shares the most important #ProstateCancer studies of the past year, spotlighting the themes of treatment intensification and the use of PARP inhibitors and radiopharmaceuticals in earlier stages of disease. 👉️ buff.ly/XWnPWIO #OncSky

010

Springer Medicine @springermedicine.com · 11/06/2026

New biological insights and pivotal clinical trials are reshaping the treatment of #BladderCancer, especially in #NMIBC and #MIBC. In this free webinar, Prof. Guru Sonpavde and Prof. @axelmerseburger.bsky.social provide an overview of the evolving standards of care. 👉️ buff.ly/6uOWY8L -- #OncSky

031

Springer Medicine @springermedicine.com · 09/06/2026

We bring you the latest updates in #diabetes research, care, and innovation from #ADA2026. 👉️ buff.ly/IGQG2qd #MedSky

001

Springer Medicine @springermedicine.com · 06/06/2026

Looking for something to listen to while travelling back from #EULAR2026? Dr. Peter Grayson shares his insights and hopes in understanding and managing #VEXAS syndrome in our latest podcast 👉️ buff.ly/6vKCqB3 #RheumSky #MedSky @natrevrheum.nature.com

011

Springer Medicine @springermedicine.com · 06/06/2026

Looking for the key highlights and top stories from #EULAR2026? Our hub page has you covered. Access the hub for free 👉️ buff.ly/QrP7KNc #RheumSky #MedSky

011

Springer Medicine @springermedicine.com · 05/06/2026

We're here at #EULAR2026 in London bringing you the latest news and developments in #rheumatology! We'll be breaking down the key highlights over on our EULAR hub 👉️ buff.ly/QrP7KNc #RheumSky

030

Springer Medicine @springermedicine.com · 03/06/2026

Since its discovery in 2020, great strides have been made in understanding and managing #VEXAS syndrome. Listen to Dr. Peter Grayson as he shares his insights and hopes 👉️ buff.ly/6vKCqB3 #RheumSky #MedSky @natrevrheum.nature.com

012

Springer Medicine @springermedicine.com · 02/06/2026

Catch up on the breaking news and key highlights from #ASCO2026 with our hub page. Unlock your free access here 👉️ buff.ly/aG3JI3W #OncSky #MedSky

000

Springer Medicine @springermedicine.com · 27/05/2026

❗️LAST CHANCE TO REGISTER❗️ Secure your place for our free CME-accredited webinar on the latest developments in #DryEyeDisease. 👉️ buff.ly/Qkpsk4b #EyeMed #DED @eyejournal.bsky.social

000

Springer Medicine @springermedicine.com · 15/05/2026

From #ESCMIDGlobal2026 - Prof. Ritu Banerjee talks through the findings of the FAST trial and the role of rapid testing in the care of patients in regions with a high #AMR prevalence. Full interview 👉️ buff.ly/Hh6bwna #IDSky #sepsis

031

Springer Medicine @springermedicine.com · 14/05/2026

From #ESCMIDGlobal2026 - Prof. W. Joost Wiersinga highlights some of the key infection-related recommendations from the Surviving #Sepsis Campaign Guidelines 2026. Watch the full video 👉️ buff.ly/gWd3RVZ #IDSky #SSC2026

011

Springer Medicine @springermedicine.com · 13/05/2026

Brought to you in collaboration with Springer Nature’s leading ophthalmology journal, Eye, our upcoming CME-accredited webinar will cover the latest developments in the diagnosis, grading, and management of #DryEyeDisease. Register now 👉️ buff.ly/ZkaI8d8 #EyeSky @eyejournal.bsky.social

001

Springer Medicine @springermedicine.com · 05/05/2026

Catch up on the top stories and key highlights in infectious diseases from #ESCMIDGlobal2026 with our hub page. Access the hub for free 👉 buff.ly/PaeR6n2 #IDSky #MedSky #MedNews

122

Springer Medicine @springermedicine.com · 29/04/2026

#GLP1 therapies are evolving - are you up to date? Enhance your knowledge with the latest news and journal insights, alongside podcasts, videos, and clinical trial summaries. Access the hub for free 👉️ buff.ly/uwSFbKF #MedSky #MedEd

022

Springer Medicine @springermedicine.com · 24/04/2026

Get insights into the underlying pathophysiological processes of Lennox–Gastaut syndrome, its burden on patients and caregivers, and opportunities to optimize #LGS diagnosis and management, with these 6 CME-accredited videos. 👉 buff.ly/Nv0y1US #NeuroSky

000

Springer Medicine @springermedicine.com · 22/04/2026

#DryEye disease can seriously impact everyday quality of life, yet it’s often hard to diagnose and manage. Join our expert led webinar to learn how new science, better diagnostics, and emerging treatments are improving long term care. 👉 buff.ly/K0dIBLG #EyeSky @eyejournal.bsky.social

000

Springer Medicine @springermedicine.com · 21/04/2026

Catch up on the top stories and key highlights in infectious diseases from #ESCMIDGlobal2026 with our hub page. Access the hub for free 👉 buff.ly/4eVfUew #IDSky #MedSky #MedNews

021

Springer Medicine @springermedicine.com · 19/04/2026

Prof. Amer Zeidan and guest experts dive into the latest innovations in molecular testing, emerging therapies & targeted treatments in R/R acute myeloid leukemia #AML in this vodcast series. All episodes available now 👉 buff.ly/ro4GLtX #OncSky #HaemOnc

000

Springer Medicine @springermedicine.com · 17/04/2026

Catch up on our conversation with Dr. Hamish Mohammed from the UKHSA about the rollout of the world's first vaccination program against #gonorrhea in England. Listen now 👉 buff.ly/m88QTA2 #IDSky #STI

000

Springer Medicine @springermedicine.com · 16/04/2026

Equip yourself to confidently implement the latest evidence-based strategies for your patients with #SLE with this free program, including expert-led videos. Learn more 👉 buff.ly/cOZzcVG #RheumSky #Lupus

010

Springer Medicine @springermedicine.com · 09/04/2026

DED is highly prevalent yet challenging to diagnose and treat. Join us and explore the latest developments in pathogenesis, diagnostics, and therapies, and gain practical guidance on management in busy clinical settings. Register now 👉 buff.ly/K0dIBLG #EyeSky #DryEye @eyejournal.bsky.social

010

Springer Medicine @springermedicine.com · 05/04/2026

Enhance your knowledge, skills and practice in molecular testing, emerging therapies, and targeted treatments in R/R #AML with this vodcast series hosted by Prof. Amer Zeidan. All episodes available now 👉 buff.ly/ro4GLtX #OncSky #HaemSky #MedEd

000

Springer Medicine @springermedicine.com · 23/03/2026

000

Springer Medicine @springermedicine.com · 22/03/2026

Around one in five cardiovascular deaths are attributable to environmental stressors. #AirPollution is perhaps the most prevalent, but how does it affect cardiovascular health? Dr. Anusha Seneviratne elaborates in our podcast. 👉 buff.ly/UChkXmD #CardioSky

011

Springer Medicine @springermedicine.com · 07/03/2026

How does air pollution affect cardiovascular health? Listen to our conversation with Dr. Anusha Seneviratne to find out more about the known mechanisms, epidemiological evidence, and preventive measures. 👉 buff.ly/LwA4qpG #CardioSky #AirPollution @anushans.bsky.social

030

Springer Medicine @springermedicine.com · 13/02/2026

❗LAST CHANCE TO REGISTER❗ What are the new opportunities and challenges that come with once-weekly #insulin regimens for type 2 #diabetes? Dr Alice Cheng discusses their safety, efficacy and implementation in this free webinar. 👉 buff.ly/SLgxR2e #T2D #MedEd

011